Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Auxilium sets sights on wider indication for Xiaflex in Dupuytren's

This article was originally published in Scrip

Executive Summary

Auxilium's Dupuytren's contracture treatment Xiaflex (collagenase clostridium histolyticum) can be used to treat multiple cords in one procedure, top-line data form a Phase III study suggest. The results from 60 patients prepare the ground for a larger study due to begin soon that could lead to an application to broaden its indication in the non-surgical treatment of this disease.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts